Cardio Diagnostics (CDIO) 10-Q2024 Q1 Quarterly report

Filed: 15 May 24, 4:30pm

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. junior Avg

New words: accredited, ACI, added, advance, advantage, Altitude, analyst, anniversary, apply, ATM, Australia, borrowing, buildout, burdensome, categorized, certified, China, chronic, classification, complaint, consent, costly, coupled, court, coverage, CPT, de, deducting, demonstrate, demonstrating, discharge, discovery, display, Distinguishing, doubt, earnout, efficiency, employer, endorsement, epidemic, exceeding, exemption, explanatory, family, FDC, fewer, finite, forced, foreseeable, fourth, gave, half, handling, HeartRisk, Hong, iii, imply, incremental, India, instance, interruption, investigational, iv, journal, Kong, labeling, landscape, larger, Leasehold, legislation, license, licensed, longevity, manufactured, memorandum, nationwide, Navierre, nonfinancial, Northland, novo, overturned, par, partnership, past, penny, PLA, Plant, PMA, portfolio, postmarket, Prager, premarket, prescribing, Procedural, proceed, Program, promulgated, Proprietary, published, reach, reaching, recall, relationship, rely, revamp, robust, RUO, secondary, setup, shareholder, similarly, small, software, solution, sponsorship, standing, stop, submit, successfully, sustaining, symptomatic, telehealth, Therapy, TIA, trend, twelve, type, UIRF, uncertainty, unissued, unregistered, York

Removed: achieve, actively, AI, banking, base, begin, book, Build, Cap, CARDO, ceased, combined, condensed, consultant, consulting, covering, effected, extremely, fall, fundamental, hand, harm, higher, hire, hospital, impacted, implement, international, introduce, limit, monitoring, negatively, originally, parent, payer, periodic, predecessor, raw, receipt, registrant, remote, renamed, requested, resale, residual, retained, scope, Specifically, stockholder, successor, supplemented, temporarily, Thalmann, timeline, transactional, treated, trust, unchanged, vendor, waived, waiver

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

CDIO similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

EXHIBIT 32.2

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with this Quarterly Report on Form 10-Q, (the “Report”) of Cardio Diagnostics Holdings, Inc. (the “Company”) for the quarter ended March 31, 2024, the undersigned, Elisa Luqman, hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of the undersigned’s knowledge and belief:

(1)	the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)	the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

May 15, 2024
		/s/ Elisa Luqman
		Elisa Luqman Chief Financial Officer (Principal Financial and Accounting Officer)